FDA-Approved Drugs Repurposing for Treating Alzheimer’s Disease using Hierarchical Cluster Analysis of Behavioral Profiles
Scientists from Brown University identified the novel usage of FDA-approved drugs by cluster analysis of behavioral profiles for the treatment of neurodegenerative disorders by utilizing CsA-type drugs, which are known to impact the neural system. The study suggests that drugs with ‘CsA-type’ behavioral profiles are potential candidates for preventing and treating Alzheimer’s disease. Repurposing FDA-approved…